Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer-Reference-Cited by-同舟云学术

Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer

Published:2018-05-07 Issue:6 Volume:48 Page:1678-1689
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Shin Gi Won¹²,Zhang Yang³,Kim Min Jung¹,Su Min-Ying³,Kim Eun-Kyung¹,Moon Hee Jung¹,Yoon Jung Hyun¹,Park Vivian Youngjean¹^ORCID

Affiliation:

1. Department of Radiology and Research Institute of Radiological Science; Severance Hospital, Yonsei University College of Medicine; Seoul Korea

2. Department of Radiology; Busan Paik Hospital, Inje University College of Medicine; Busan Korea

3. Department of Radiological Sciences; Tu & Yuen Center for Functional Onco-Imaging. University of California; Irvine California USA

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmri.26176/fullpdf

Reference38 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Association between parenchymal enhancement of the contralateral breast in dynamic contrast-enhanced MR imaging and outcome of patients with unilateral invasive breast cancer;Velden;Radiology,2015

3. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004

4. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials;Fisher;Lancet,2004

5. Prediction of low versus high recurrence scores in estrogen receptor-positive, lymph node-negative invasive breast cancer on the basis of radiologic-pathologic features: comparison with oncotype DX test recurrence scores;Dialani;Radiology,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Background Parenchymal Enhancement;Radiologic Clinics of North America;2024-07

2. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer;Magnetic Resonance Imaging;2023-12

3. Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study;Frontiers in Oncology;2023-08-04

4. Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study;Radiology;2023-05-01

5. Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant Therapy;Academic Radiology;2022-10